FROST PHILLIP MD ET AL
SEC insider (Form 3/4/5 filer). CIK 0000898860. 10% Owner at NOCOPI TECHNOLOGIES INC/MD/ (NNUP) and 3 other issuers. 91 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in MIAMI, FL.
Companies FROST PHILLIP MD ET AL has filed insider reports for
- NOCOPI TECHNOLOGIES INC/MD/ (NNUP): 10% Owner
- Cocrystal Pharma, Inc. (COCP): Director, 10% Owner
- OPKO HEALTH, INC. (OPK): Director, Officer, 10% Owner, CEO & Chairman
- Fluent, Inc. (FLNT): 10% Owner
FROST PHILLIP MD ET AL
CIK: 0000898860
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (91 total)
- Sep 11, 2026NNUP
NOCOPI TECHNOLOGIES INC/MD/
AwardIndirect21.9K shares- - Aug 5, 2026COCP
Cocrystal Pharma, Inc.
PurchaseIndirect10K shares at avg. $0.98$10K - Aug 3, 2026COCP
Cocrystal Pharma, Inc.
PurchaseIndirect75K shares at avg. $0.94$71K - Feb 24, 2026COCP
Cocrystal Pharma, Inc.
PurchaseIndirect20K shares at avg. $1.00$20K - Feb 6, 2026COCP
Cocrystal Pharma, Inc.
PurchaseIndirect50K shares at avg. $0.95$47K - Jan 9, 2026COCP
Cocrystal Pharma, Inc.
AwardDirectStock Options (Right to Buy)
24.6K shares- - Dec 31, 2025COCP
Cocrystal Pharma, Inc.
PurchaseIndirect50K shares at avg. $0.95$47K - Dec 30, 2025COCP
Cocrystal Pharma, Inc.
PurchaseIndirect20K shares at avg. $0.97$19K - Dec 26, 2025COCP
Cocrystal Pharma, Inc.
PurchaseIndirect40K shares at avg. $0.97$39K - Dec 24, 2025COCP
Cocrystal Pharma, Inc.
PurchaseIndirect25K shares at avg. $0.97$24K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 |  NNUP NOCOPI TECHNOLOGIES INC/MD/ | Award | 21,930 | - | $0 | Indirect |
| Aug 5, 2026 |  COCP Cocrystal Pharma, Inc. | Purchase | 10,000 | $0.98 | $9,816 | Indirect |
| Aug 3, 2026 | COCP Cocrystal Pharma, Inc. | Purchase | 75,000 | $0.94 | $70,590 | Indirect |
| Feb 24, 2026 | COCP Cocrystal Pharma, Inc. | Purchase | 20,000 | $1.00 | $19,952 | Indirect |
| Feb 6, 2026 | COCP Cocrystal Pharma, Inc. | Purchase | 50,000 | $0.95 | $47,280 | Indirect |
| Jan 9, 2026 | COCP Cocrystal Pharma, Inc. | Award Stock Options (Right to Buy) | 24,615 | - | - | Direct |
| Dec 31, 2025 | COCP Cocrystal Pharma, Inc. | Purchase | 50,000 | $0.95 | $47,275 | Indirect |
| Dec 30, 2025 | COCP Cocrystal Pharma, Inc. | Purchase | 20,000 | $0.97 | $19,310 | Indirect |
| Dec 26, 2025 | COCP Cocrystal Pharma, Inc. | Purchase | 40,000 | $0.97 | $38,944 | Indirect |
| Dec 24, 2025 | COCP Cocrystal Pharma, Inc. | Purchase | 25,000 | $0.97 | $24,258 | Indirect |
1-10 of 91 transactions